News

FRANKFURT. Each year, several thousand women in Germany die from ovarian cancer. In many cases, the disease is only detected when it is very advanced and metastases have already formed – usually in the intestines, abdomen or lymph nodes. At such a late stage, only

A groundbreaking technology with immense potential in treating ischemic retinopathy in premature infants and diabetic patients has been developed by Professor Byoung Heon Kang and his research team in the Department of Biological Sciences at UNIST, in collaboration with Professor Dong Ho Park’s team at

HOUSTON – (Jan. 24, 2023) – Rice University researchers in the lab of chemist Han Xiao have identified a promising new immunological pathway to treat stubborn bone tumors, one of most prevalent forms of metastases in breast cancer patients. Credit: (Photo by Gustavo Raskosky/Rice University)

Barcelona, 24 January 2024 – Cancer treatments, including chemotherapy, in addition to killing a large number of tumour cells, also result in the generation of senescent tumour cells (also called “zombi cells”). While senescent cells do not reproduce, they do, unfortunately, generate a favourable environment

“[…] we identified LTBR as a potential target for cancer immunotherapy and a marker of immune infiltration and poor prognosis.” Credit: 2024 Wu et al. “[…] we identified LTBR as a potential target for cancer immunotherapy and a marker of immune infiltration and poor prognosis.”

A research team led by Professor Anskar Leung Yu-hung, from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has identified PLK4 as a novel therapeutic target for acute myeloid leukaemia (AML) carrying the TP53 mutation.

A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population. Credit: Vanderbilt University Medical Center A 10-year follow up study of nearly 2,500 U.S.

Worldwide, 40 percent of all children with cancer die from their disease*. In countries like Germany, which are among the global leaders in healthcare, 20 percent of all children with cancer do not survive their disease. Credit: Marius Stark/KiTZ Worldwide, 40 percent of all children

On January 3, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer Center published a new brief report in Oncoscience (Volume 11), entitled, “My battle with cancer. Part 1.” Credit: 2024 Blagosklonny On January 3, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell

A new research perspective was published in Oncotarget’s Volume 15 on January 16, 2024, entitled, “Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma.” Credit: 2024 El-Masri et al. A new research perspective was published in Oncotarget’s Volume 15 on January